HomeHealth articlesrhinoscleromaWhat Is Rhinoscleroma?

Rhinoscleroma: Unusual Upper Respiratory Infection

Verified dataVerified data
0

4 min read

Share

Rhinoscleroma is a chronic upper respiratory tract granulomatous disease. Read this article to know about it in detail.

Medically reviewed by

Dr. Laxmi Narasimha G

Published At March 29, 2023
Reviewed AtAugust 14, 2023

What Is Rhinoscleroma?

Rhinoscleroma is a chronic granulomatous disease caused by a bacteria known as Klebsiella rhinoscleromatis. It is a gram-negative rod-like shaped bacteria. This disease usually appears in the nasal mucosa but can progress to any part of the upper respiratory tract.

What Is the Historical Background of Rhinoscleroma?

Hebra first described rhinoscleroma in 1870. Polish surgeon Johann von Mikulich described the histologic features of rhinoscleroma in 1877. In 1882 von Frisch identified the causative organism. In 1961, Steffen and Smith proposed that Klebsiella rhinoscleromatis is the main etiologic factor responsible for rhinoscleroma.

What Is the Epidemiology of Rhinoscleroma?

This disease is more prevalent in regions of Africa, Southeast Asia, Mexico, Central and South America, and Eastern Europe countries. However, sporadic cases of rhinoscleroma have also been reported worldwide. Five percent of all cases are found in Africa. In recent years, this disease has been rising in America, usually in the immigrant population.

This disease can affect a person of any race and is found in more females than males. Generally affecting people of age 10 to 30 years.

What Are the Clinical Features of Rhinoscleroma?

The nasal cavity is the most commonly affected area in 95 to 100 percent of the cases, followed by the nasopharynx (18 to 43 percent), larynx (15 to 40 percent), trachea (12 percent) and bronchi (two to seven percent).

The disease affects mostly middle-aged women living in poor hygienic conditions. Human beings are the only host for Klebsiella rhinoscleromatis. The bacteria travel via nasal droplets or contaminated material.

There are three stages of rhinoscleroma -

1. Catarrhal Phase - This is the initial phase in which the patient has nonspecific rhinitis (irritation and swelling of the mucus membrane of the nose) with foul-smelling discharge, epistaxis, and nasal obstruction. This stage can last for weeks or months.

2. Granulomatous Phase (Proliferative or Nodular) - The clinical features are more prominent in the granulomatous phase, which involves a granulomatous nodular mass that causes nasal obstruction. The mucosal tissue inside the nose becomes bluish-red, and the symptoms include bleeding noses, nasal obstruction, a hoarse voice, and thickening or numbing of the soft palate.

3. Sclerotic Phase (Cicatricial or Fibrotic) - If this condition is left untreated, it leads to a sclerotic phase. In this phase, permanent deformities can be seen, which include nasal deformities, anosmia (loss of smell), dysphonia (a disorder of voice), dysphasia (language disorder), oral anesthesia, and stridor (high-pitched whistling sound while breathing).

The initial nodule is small in size and intra-nasal, and it can also grow into an exophytic giant tumor, which can even obstruct the entire respiratory tract. In rare cases, it may also extrude into the oral cavity, the skull base, the orbit, and the brain.

How to Diagnose Rhinoscleroma?

I. Cytologic Methods -

The diagnosis of rhinoscleroma can be made by cytologic methods as they are easy to perform and do not cause any pain. In these tests, small amounts of body fluids can be taken and evaluated in the lab to find the causative agent. For this condition, the specimen or sample is directly taken from the lesion and assessed under the microscope.

  • Chronic upper respiratory tract infections can be diagnosed by tissue biopsy of the lesion.

  • Nasal endoscopy can be done, which helps identify all three stages of rhinoscleroma.

  • Bronchoscopy (a procedure to look at lungs or air passages) can be done in the initial stage for early diagnosis of rhinoscleroma.

The positive finding of this disease can be made by culturing the sample with MacConkey agar and evaluating it under the microscope. However, it is only helpful in 50 to 60 percent of the cases.

II. Radiographic Features -

1. Computed Tomography -

The characteristic radiological feature of rhinoscleroma can be easily seen in computed tomography (CT) scans, which is the presence of nasal mass.

  • Computed tomography for primary nasal and nasopharyngeal rhinoscleroma soft-tissue masses of variable sizes can be seen.

  • Lesions are non-enhancing and homogeneous and have distinct borders.

  • The lesions do not invade the surrounding tissues.

  • The lesions may be seen, causing irregular narrowing of the airway.

  • In the trachea, crypt-like irregularities can be seen.

  • Thickening of walls and nodules can also be seen.

2. MRI (Magnetic Resonance Imaging) - In MRI, nasal masses can be visualized, obstructing the nasal cavity, and secretions may get retained in the various sinuses.

What Is the Treatment of Rhinoscleroma?

The treatment for rhinoscleroma includes long-term antibiotic therapy and surgical intervention in patients with obstruction in the nasal cavity.

Long-term Antibiotic Therapy -

The choice of long-term antibiotic therapy should be planned based on the age and sex of the patient. Antibiotics such as Cephalosporins and Clindamycin can be given in cases with bacterial infections, and Ciprofloxacin can be prescribed for sclerotic lesions.

Surgical Procedures -

Surgery combined with antibiotic therapy is the best treatment in cases with granulomatous disease, nasal or pharyngeal obstruction, or nasal sinus involvement.

  • Tracheotomyis a surgical airway management procedure in which the surgeon makes a hole in the front of the neck to the trachea. This is beneficial in cases with laryngeal obstruction in the granulomatous and sclerotic stages.

  • Plastic surgery can be done in patients with perforations in the nasal cavity, pharynx, larynx, or trachea.

  • Granulomatous lesions can be effectively treated by open excision surgery.

  • Laser therapy or surgery can treat airway obstruction and tissue deformities.

  • Rhinoplasty (surgery to change the shape of the nose) can be done to treat external nasal deformities.

  • Palatal symptoms can be corrected by uvulopalatopharyngoplasty (a surgical procedure to open the upper airways).

What Is the Differential Diagnosis of Rhinoscleroma?

The differential diagnosis of other forms of nasal masses includes granulomatous and neoplastic disease that may resemble rhinoscleroma.

Granulomatous diseases include -

  • Bacterial infections such as tuberculosis, leprosy, and syphilis.

  • Fungal infections such as histoplasmosis and sporotrichosis.

  • Parasitic infections such as mucocutaneous leishmaniasis

Neoplasms such as lymphoma.

The various clinical findings that help differentiate rhinoscleroma from other nasal malignancies include-

  • Expansion of the nasal cavities.

  • Scalloping of the sinus wall.

  • Lack of bone destruction.

Conclusion

Rhinoscleroma is an uncommon condition that usually depends upon the hygiene of the patient. Moreover, this is rarely lethal unless it causes any airway obstruction. It can be treated easily with antibiotic therapy but can go for long-term, and surgery can also be performed in case of any airway compromise. The recurrence rate of this condition is also high if precautions are not taken after the treatment. Patients should immediately consult a doctor if symptoms are found, as, with delay, the rate of severity can also increase.

Frequently Asked Questions

1.

Please Give a Brief Overview of Rhinoscleroma in Relation to the Nasal Cavity.

 
A chronic granulomatous illness that affects the nose and other components of the upper respiratory tract, rhinoscleroma can also spread to other parts of the body. Infection with the bacteria Klebsiella rhinoscleromatis ultimately leads to the development of rhinoscleroma.

2.

What Are the Treatment Options for Rhinoscleroma Affecting the Nasal Cavity?

The administration of antibiotics over an extended period of time frequently results in the complete elimination of this particular infection. The selection of extended antibiotic treatment should be influenced by the various factors of the patient, including age and gender. A subsequent biopsy may be conducted in order to ascertain the optimal duration of antibiotic treatment.

3.

What Are the Diagnostic Methods for Rhinoscleroma?

 
The diagnosis of this persistent infectious disease affecting the upper respiratory tract typically involves the utilization of tissue biopsy of the lesions. The examination of the nasal cavity using endoscopy (the insertion of a flexible tube with a light) reveals indications of all three stages of scleroma( formation of chronic granulomatous), namely catarrhal (inflammation of the mucous), granulomatous, and sclerotic (hardening). The utilization of bronchoscopy plays a significant role in the timely identification of rhinoscleroma.

4.

Which Types of Cells Are Present in Rhinoscleroma?

 
Mikulicz cells (MCs) play a crucial role in the diagnosis of Rosai-Dorfman disease (RDD), being particularly prominent during the granulomatous phase while being few or absent during the catarrhal or sclerotic phases.

5.

What Are the Distinguishing Features of Rhinoscleroma?

 
However, lesions connected to rhinoscleroma may also affect the larynx, nasopharynx, oral cavity, paranasal sinuses, or soft tissues, including the lips, nose, trachea, and bronchi. Rhinoscleroma typically affects the nasal cavity. The upper lip's mucosal lining may have a tumor protracted from it as a sign of rhinoscleroma.

6.

What Is the Underlying Pathological Mechanism of Rhinoscleroma?

Rhinoscleroma, often known as RS, is a chronic and particular disease that affects the nose and the upper respiratory passages which is caused by the Klebsiella rhinoscleromatis bacilli. Rhinoscleroma can be efficiently controlled with antibiotics as well as surgical debridement and repair; nonetheless, recurrence rates are significant in the effectiveness of management strategies.

7.

What Are the Clinical Manifestations Associated With Rhinoscleroma?

Those who have this condition may experience symptoms such as bleeding from the nose, nasal blockage (or obstruction elsewhere in the respiratory tract), loss of the ability to smell, hoarse voice, and thickening of or numbing of the soft palate.

8.

Which Pharmaceutical Agents Are Commonly Used for the Treatment of Rhinoscleroma?

 
The medication used in the treatment of rhinoscleroma includes Tetracycline as the primary medication of choice in this condition. Ciprofloxacin and Rifampin are two other additional antibiotics. Clindamycin and other cephalosporins of the third generation are effective medicines for treating bacterial superinfections.

9.

What Are Klebsiella Pneumoniae Rhinoscleroma Subspecies?

The K. pneumoniae subspecies rhinoscleromatis is the primary cause of respiratory scleroma, commonly known as rhinoscleroma. This condition is characterized by a persistent granulomatous infection that affects the nasal passages and other components of the respiratory system.

10.

What Is the Preferred Treatment for Klebsiella Rhinoscleroma?

 
Cephalosporins of the third and fourth generation, Quinolones, and Carbapenems are the most effective antibiotics for treating Klebsiella infections. The utilization of more modern medications and monotherapy for the treatment of Klebsiella pneumoniae is equally as effective as combination treatments. 

11.

What Diseases Does Klebsiella Pneumoniae Cause?

 
Klebsiella pneumoniae is a gram-negative, encapsulated, non-motile bacteria that is present in the environment. It has been linked to cases of pneumonia in patient populations that have a history of alcohol use disorder or diabetes mellitus and it necessitates entry into the respiratory tract, or alternatively, the bloodstream for the purpose of causing a bloodstream infection.
Source Article IclonSourcesSource Article Arrow
Dr. Laxmi Narasimha G
Dr. Laxmi Narasimha G

Otolaryngology (E.N.T)

Tags:

rhinoscleroma
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

rhinoscleroma

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy